关节挛缩综合征患儿的麻醉结局:无高热证据
事后病例对照分析未发现AMC患儿术中最高体温或高热 odds 升高。
核心结论
- 关节挛缩综合征患儿麻醉挑战包括神经肌肉疾病负担重和困难外周静脉置管,证据提示困难气道和术中血流动力学不稳更常见。
- 未发现AMC患儿术中高热或高代谢反应 odds 增加的证据,但需更确证性研究。
研究设计与样本
- 回顾性队列研究纳入1972至2013年接受麻醉的0至25岁关节挛缩综合征患儿,AMC 45例(264次麻醉)与DAS 16例(105次麻醉)比较。
- 事后病例对照分析将AMC患者按1:2比例匹配无关节挛缩患者,评估主要结局术中最高体温。
临床怎么用
- 对关节挛缩综合征患儿应预判困难外周静脉置管并提前准备替代通路。
- 对AMC患儿需警惕困难气道和术中血流动力学不稳,做好相应预案。
- 现有证据不支持将AMC患儿术中高热常规归因于高代谢反应,但仍需个体化监测。
局限性
- 研究为回顾性病历回顾,样本量有限(AMC 45例、DAS 16例),结论需更确证性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Arthrogryposis syndromes are a heterogeneous group of disorders characterized by congenital joint contractures often requiring multiple surgeries during childhood to address skeletal and visceral abnormalities. Previous reports suggest that these children have increased perioperative risk, including hypermetabolic events discrete from malignant hyperthermia, difficult airway management, isolated hyperthermia, and difficult IV line placement. We sought to compare children with arthrogryposis multiplex congenita (AMC) versus the less severe, distal arthrogryposis syndromes (DAS) and to evaluate possible intraoperative hyperthermia of patients with AMC. We hypothesized that children with AMC had a greater incidence of intraoperative hyperthermia and more difficulty with airway management and IV access. METHODS: Children aged 0 to 25 years with arthrogryposis syndromes who underwent anesthesia from 1972 to 2013 were identified. The medical records were reviewed for demographics, arthrogryposis type, and anesthetic complications. AMC subjects were compared with DAS subjects. To evaluate the probability of hyperthermia and hypermetabolic responses of patients with AMC, we performed a post hoc case-control analysis. Patients with AMC were matched in a 1:2 ratio to patients without arthrogryposis to evaluate the primary outcome of maximum intraoperative temperature. RESULTS: Forty-five patients with AMC and 16 patients with DAS underwent 264 and 105 unique anesthetics, respectively. There was no significant difference in intraoperative hyperthermia or hypermetabolic events (odds ratio [OR], 0.94; 95% confidence interval [CI], 0.36-2.47; P = .90). Children with AMC were more likely to have difficult IV access (OR, 7.1; 95% CI, 1.81-27.90; P = .005). Additional evidence suggested that difficult airway management (OR, 4.06; 95% CI, 1.01-16.39; P = .049) and hemodynamic instability (OR, 4.22; 95% CI, 1.03-17.26; P = .045) were more likely in children with AMC. From post hoc case-control analysis, there was no significant difference in the mean maximum intraoperative temperature (estimated difference +0.04°C; 95% CI, -0.14 to +0.22; P = .64) or odds of intraoperative hyperthermia (OR, 1.49; 95% CI, 0.78-2.82; P = .223) for patients with AMC compared with control subjects. CONCLUSIONS: Children with arthrogryposis syndromes present challenges to the anesthesia and surgical teams, including greater neuromuscular disease burden and challenging peripheral IV placement, with additional evidence suggesting difficult airway management and intraoperative hemodynamic instability. Although more definitive studies are warranted, we did not find evidence of increased odds of intraoperative hyperthermia or hypermetabolic responses.
引用
- Gleich SJ, Tien M, Schroeder DR, et al. Anesthetic Outcomes of Children With Arthrogryposis Syndromes: No Evidence of Hyperthermia. Anesth Analg. 2017. PMID: 28099287. doi:10.1213/ANE.0000000000001822
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。